![]() |
市场调查报告书
商品编码
1663309
气管内插管:市场洞察·竞争情形·市场预测 (~2032年)Endotracheal Tube - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
气管内插管市场规模预计将从 2024 年的 15.8267 亿美元增长到 2032 年的 21.7359 亿美元,预测期内的复合年增长率为 4.09%。
慢性呼吸道疾病和肿瘤疾病的发生率不断上升,以及外科手术和创伤病例的增加,推动了气管插管的需求。此外,抗菌涂层管等创新以及主要参与者的改进设计也在推动其应用。这些因素共同扩大了全球气管插管市场,并进一步推动预测期内的市场成长。
市场动态:
受慢性呼吸系统疾病盛行率上升、癌症患者数量增加和技术进步的推动,全球气管内管市场有望显着成长。
根据澳洲健康与福利研究所 (2022) 的数据,估计约有 850 万人(占澳洲人口的 34%)患有慢性呼吸道疾病。 《全球疾病负担(2023年)》报告称,全球每20人中就有1人患有慢性呼吸系统疾病。这些疾病常常导致严重的呼吸窘迫,需要频繁的医疗干预,包括气道管理。在紧急情况下,机械通气对于维持足够的氧合至关重要,而气管插管是此类手术的主要工具。污染、吸烟和人口老化等因素持续推高全球呼吸系统疾病的发生率,刺激气管插管市场的需求。
同时,全球癌症发生率的上升进一步推动了市场的成长。根据 GLOBOCAN(2022)的数据,全球约有 2,000 万例新发癌症病例,预计到 2045 年将增加到 3,260 万例。许多癌症患者,尤其是接受呼吸手术的患者,需要透过插管进行气道管理。例如,肺癌患者在活检、肿瘤切除和术后护理等过程中经常会出现呼吸困难,这些过程都需要气管插管。此外,化疗和放疗等癌症治疗可能导致气道阻塞和呼吸衰竭等併发症,进一步增加了对机械呼吸器的需求。
技术进步在推动市场成长方面也发挥关键作用。 2021年11月,GE医疗集团首个用于辅助气管插管的X射线AI解决方案获得FDA批准。作为 GE Healthcare 重症监护套件 2.0 的一部分,该 AI 工具是业界首个整合到行动 X 光机中的 AI 演算法集合,可提供自动测量、病例优先排序和品质控制。这些创新将提高程序的准确性,减少放置错误,改善患者的治疗效果,并进一步提高气管插管的采用率。
儘管有这些成长动力,市场也面临课题。插入併发症,包括对牙齿、声带和气管的潜在损害,以及呼吸器相关性肺炎 (VAP) 的风险,可能会阻碍市场扩张。这些风险凸显了持续培训、改善设备设计和遵守安全协议以减轻不利后果的必要性。
本报告提供全球气管内插管的市场调查,彙整市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Endotracheal Tube Market by Product Type (Standard, Reinforced, Coated, and Others), Cuff Type (Cuffed and Uncuffed/Cuffless), Intubation Route (Nasal, Oral, and Others), Age Group (Adult and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of chronic respiratory and oncological disorders, growing surgical procedures, rising number of trauma and accident cases, and increase in product development activities by key market players across the globe.
The endotracheal tubes market was valued at USD 1,582.67 million in 2024, growing at a CAGR of 4.09% during the forecast period from 2025 to 2032 to reach USD 2,173.59 million by 2032. The rising prevalence of chronic respiratory and oncological disorders, along with an increase in surgical procedures and trauma cases, is driving demand for endotracheal tubes. Additionally, innovations like antimicrobial-coated tubes and improved designs by key market players are boosting their adoption. Together, these factors are expanding the global market for endotracheal tubes further propelling the market growth during the forecast period from 2025 to 2032.
Endotracheal Tubes Market Dynamics:
The global endotracheal tubes market is poised for significant growth, driven by the increasing prevalence of chronic respiratory conditions, rising cancer cases, and technological advancements.
According to the Australian Institute of Health and Welfare (2022), approximately 8.5 million people, or 34% of Australia's population were estimated to have chronic respiratory conditions. On a global scale, the Global Burden of Disease (2023) reported that 1 in 20 individuals suffers from chronic respiratory diseases. These conditions often lead to severe breathing difficulties, necessitating frequent medical interventions that involve airway management. In critical scenarios, mechanical ventilation is essential to maintain proper oxygenation, with endotracheal tubes being a primary tool in such procedures. Factors like pollution, smoking, and aging populations continue to drive the global incidence of respiratory diseases, thereby fueling market demand for endotracheal tubes.
In parallel, the rising global burden of cancer further escalates market growth. As per GLOBOCAN (2022), there were an estimated 20 million new cancer cases globally, with projections indicating an increase to 32.6 million by 2045 . Many cancer patients particularly those undergoing respiratory-related surgeries require airway management through intubation. For instance, lung cancer patients often face breathing difficulties during procedures such as biopsies, tumor resections, and post-operative care, all of which necessitate endotracheal tubes. Additionally, cancer treatments like chemotherapy and radiation may cause complications such as airway obstruction or respiratory failure, further increasing the demand for mechanical ventilation devices.
Technological advancements are also playing a crucial role in propelling market growth. In November 2021, GE Healthcare received FDA clearance for the first X-ray artificial intelligence (AI) solution designed to assist in endotracheal tube placement. This AI tool, part of GE Healthcare's Critical Care Suite 2.0, is an industry-first collection of AI algorithms integrated into a mobile X-ray device, offering automated measurements, case prioritization, and quality control. Such innovations enhance procedural accuracy, reduce placement errors, and improve patient outcomes, further boosting adoption rates of endotracheal tubes.
Despite these growth drivers, the market faces challenges. Complications during insertion, including potential damage to teeth, vocal cords, or the trachea, along with the risk of ventilator-associated pneumonia (VAP), may hinder market expansion. These risks highlight the need for ongoing training, improved device designs, and adherence to safety protocols to mitigate adverse outcomes.
In conclusion, the interplay of rising chronic respiratory diseases, increasing cancer prevalence, and technological innovations is expected to drive the global endotracheal tube market. However, addressing procedural risks and infection control remains vital to sustain long-term growth.
Endotracheal Tubes Market Segment Analysis:
Endotracheal Tubes Market by Product Type (Standard, Reinforced, Coated, and Others), Cuff Type (Cuffed and Uncuffed/Cuffless), Intubation Route (Nasal, Oral, and Others), Age Group (Adult and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the cuff type segment of the overall endotracheal tubes market, the cuffed endotracheal tubes are expected to hold the largest share in the year 2024. Cuffed endotracheal tubes are increasingly driving the growth of the endotracheal tube market due to their advanced design and substantial benefits in airway management. The primary advantage of cuffed endotracheal tubes lies in the cuff a balloon-like component that inflates once the tube is in place, creating a seal around the trachea. This seal is critical for ensuring that the airway remains secure, preventing air leaks, and reducing the risk of aspiration, which occurs when stomach contents enter the lungs. Additionally, cuffed endotracheal tubes allow for more precise control of ventilation pressures, which is crucial for patients requiring mechanical ventilation. The ability to adjust cuff pressure helps optimize ventilation and minimizes the risk of ventilator-associated pneumonia (VAP) by reducing the potential for contamination and infection. This is especially important in intensive care units (ICUs) and emergency settings where patients are at high risk for such infections.
The market for cuffed endotracheal tubes is further bolstered by ongoing innovations in cuff technology and materials. Modern cuff designs use advanced materials that are less prone to air leaks and are more comfortable for patients. These improvements contribute to better patient outcomes and higher safety standards, making cuffed tubes a preferred choice in many clinical scenarios thereby boosting the overall market of cuffed endotracheal tubes.
Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global endotracheal tubes market during the forecast period.
North America is expected to dominate the overall Endotracheal Tubes market:
Among all the regions, North America is expected to hold the largest share of the global endotracheal tubes market in 2024. The growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region. Additionally, recent product developmental activities such as product approval and launches are expected to aid in the growth of the North American endotracheal tubes market during the forecast period from 2025 to 2032.
As per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, emphysema, and chronic bronchitis cause severe breathing difficulties and frequent exacerbations, often requiring intubation and mechanical ventilation in advanced stages. Endotracheal tubes are essential for securing the airway and providing precise ventilation support for the patients thereby escalating the overall market across the region. Furthermore, as per the recent data and stats provided by the Centre for Disease Control and Prevention (2023), in 2022, the admission rate of mothers to an intensive care unit (ICU) during delivery hospitalization was 1.8 per 1,000 live births. The admission rate of mothers to an intensive care unit (ICU) can significantly boost the market for endotracheal tubes due to the critical need for airway management in severe obstetric complications. Conditions such as severe preeclampsia, postpartum hemorrhage, or complications during labor and delivery may necessitate emergency intubation and mechanical ventilation to ensure maternal safety and optimal respiratory support thereby boosting the overall market of endotracheal tubes.
According to the recent data and stats provided by the Centre for Disease Control and Prevention (2024), there were 24.8 million physician office visits and 25.5 million emergency department visits for unintentional road traffic injuries. Road traffic accidents often cause severe injuries that impair breathing, requiring immediate airway management. Endotracheal tubes are essential for securing the airway, ensuring proper ventilation, and preventing complications in emergency settings. The high frequency of such accidents drives demand for these tubes to manage critical airway needs efficiently.
Therefore, the interplay of the above-mentioned factors in the region is expected to boost the North America endotracheal tubes market during the forecast period.
Endotracheal Tubes Market Key Players:
Some of the key market players operating in the endotracheal Tubes market include Medtronic PLC, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc., ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co., Ltd., ROYAX, S.R.O, Sumi, HUM Gesellschaft fur Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L, and others.
Recent Developmental Activities in the Endotracheal Tubes Market:
Key Takeaways from the Endotracheal Tubes Market Report Study:
Target Audience Who Can be Benefited from this Endotracheal Tubes Market Report Study:
Frequently Asked Questions for the Endotracheal Tubes Market: